<DOC>
	<DOCNO>NCT00935740</DOCNO>
	<brief_summary>Monocyte tissue factor ( TF ) characterize Class C heart failure ( HF ) vs. 25 age-matched volunteer . TF 2.9 fold high ( p &lt; 0.001 ) HF patient vs. control . HF patient show increased clinical event ( RR=1.29 , p=0.04 ) compare procoagulant activity above/below median . HF associate increase TF expression .</brief_summary>
	<brief_title>Tissue Factor Expression Stage C Heart Failure</brief_title>
	<detailed_description>Monocyte tissue factor ( TF ) characterize Class C heart failure ( HF ) vs. 25 age-matched volunteer . TF 2.9 fold high ( p &lt; 0.001 ) HF patient vs. control . HF patient show increased clinical event ( RR=1.29 , p=0.04 ) compare procoagulant activity above/below median . HF associate increase TF expression . Previous study suggest marker coagulation elevate heart failure ( HF ) . Tissue factor ( TF ) play cardinal role initiate coagulation cascade . This study determine TF expression HF association disease progression . Methods : Monocytes obtain 50 NYHA function class II-IV HF patient 25 age-matched disease-free volunteer . TF protein , TF procoagulant activity , tissue factor pathway inhibitor ( TFPI ) determine .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Thromboplastin</mesh_term>
	<criteria>Heart failure subject symptomatic heart failure ( New York Heart Association [ NYHA ] functional class II IV ) due either idiopathic dilate cardiomyopathy ischemic cardiomyopathy leave ventricular ejection fraction &lt; 0.35 .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>thromboembolic disease</keyword>
	<keyword>thromboplastin</keyword>
	<keyword>hypercoagulability</keyword>
	<keyword>congestive heart failure</keyword>
</DOC>